ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q3 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,158,612 | -11.7% | 899,700 | 0.0% | 1.07% | -1.8% |
| Q2 2023 | $18,299,898 | -6.5% | 899,700 | 0.0% | 1.09% | -22.9% |
| Q1 2023 | $19,577,472 | -29.8% | 899,700 | 0.0% | 1.42% | -18.2% |
| Q4 2022 | $27,881,703 | +21.5% | 899,700 | 0.0% | 1.73% | -1.9% |
| Q3 2022 | $22,951,000 | +25.7% | 899,700 | 0.0% | 1.77% | +2.5% |
| Q2 2022 | $18,264,000 | -17.9% | 899,700 | 0.0% | 1.72% | -9.1% |
| Q1 2022 | $22,259,000 | – | 899,700 | – | 1.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
| EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
| 5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
| Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
| Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
| Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
| Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
| BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
| Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |